Table 2 Common all-causality AES ( ≥ 15% in either arm) in MONALEESA-2, -3 and -7 (pooled data, safety set).

From: Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer

n (%)

Ribociclib + endocrine therapya, n = 1065

Placebo + endocrine therapy, n = 818

Grade (CTCAE v4.03)

All

3

4

All

3

4

Any AE

1052 (99)

699 (66)

158 (15)

782 (96)

245 (30)

26 (3)

Haematologic AEs

 Neutropeniab

788 (74)

550 (52)

91 (9)

43 (5)

12 (1)

1 (<1)

 Leukopeniac

330 (31)

180 (17)

13 (1)

36 (4)

7 (1)

0

 Anaemiad

200 (19)

28 (3)

2 (<1)

51 (6)

12 (1)

0

Non-haematologic AEs

 Nausea

475 (45)

15 (1)

0

219 (27)

4 (<1)

0

 Fatigue

348 (33)

19 (2)

1 (<1)

249 (30)

4 (<1)

0

 Diarrhoea

317 (30)

16 (2)

0

176 (22)

5 (1)

0

 Arthralgia

310 (29)

7 (1)

1 (<1)

243 (30)

8 (1)

0

 Vomiting

284 (27)

21 (2)

0

128 (16)

3 (<1)

0

 Alopecia

256 (24)

0

0

97 (12)

0

0

 Constipation

253 (24)

8 (1)

0

129 (16)

0

0

 Headache

252 (24)

5 (<1)

0

177 (22)

4 (<1)

0

 Hot flush

223 (21)

2 (<1)

0

200 (24)

0

0

 Cough

218 (21)

0

0

132 (16)

0

0

 Back pain

211 (20)

20 (2)

0

153 (19)

7 (1)

0

 Rash

187 (18)

6 (1)

0

63 (8)

0

0

 Pruritus

169 (16)

3 (<1)

0

47 (6)

0

0

 Decreased appetite

163 (15)

6 (1)

0

101 (12)

1 (<1)

0

 Increased ALT

161 (15)

71 (7)

15 (1)

48 (6)

8 (1)

0

  1. AE adverse event, ALT alanine transferase, CTCAE Common Terminology Criteria for Adverse Events.
  2. aPatients from MONALEESA-2 (ribociclib plus letrozole group), MONALEESA-3 (ribociclib plus fulvestrant group) and MONALEESA-7 (ribociclib plus non-steroidal aromatase inhibitor group).
  3. b“Neutropenia” includes “neutropenia,” “decreased neutrophil count,” “febrile neutropenia,” “granulocytopenia” and “neutropenia sepsis.”
  4. c“Leukopenia” includes “leukopenia,” “decreased white blood cell count,” “lymphopenia” and “decreased lymphocyte count.”
  5. d“Anaemia” includes “anaemia,” “decreased haemoglobin,” “macrocytic anaemia” and “decreased red blood cell count.”